QuantumPharm, Inc. (2228) Income Statement

13 Followers

QuantumPharm, Inc. Income Statement

Last quarter (Q4 2025), QuantumPharm, Inc.'s total revenue was ¥280.78M, an increase of 197.27% from the same quarter last year. In Q4, QuantumPharm, Inc.'s net income was ¥40.27M. See QuantumPharm, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	¥ 781.85M	¥ 266.43M	¥ 174.42M	¥ 133.35M	¥ 62.80M
Gross Profit	¥ 544.71M	¥ 123.43M	¥ 48.24M	¥ 66.09M	¥ 32.78M
Operating Expenses	¥ 1.04B	¥ 807.63M	¥ 770.55M	¥ 591.40M	¥ 332.22M
Depreciation and Amortization	¥ 112.61M	¥ 83.38M	¥ 121.72M	¥ 47.97M	¥ 23.13M
EBITDA	¥ -383.89M	¥ -631.38M	¥ -1.78B	¥ -1.38B	¥ -2.11B
Operating Income	¥ -496.50M	¥ -684.21M	¥ -722.31M	¥ -525.31M	¥ -299.43M
Other Income/Expenses	¥ 628.36M	¥ -830.66M	¥ -1.18B	¥ -913.30M	¥ -1.84B
Pretax Income	¥ 131.85M	¥ -1.51B	¥ -1.91B	¥ -1.44B	¥ -2.14B
Net Income	¥ 120.54M	¥ -1.52B	¥ -1.91B	¥ -1.44B	¥ -2.14B
Per Share Metrics
Basic EPS	¥ 0.03	¥ -0.79	¥ -0.79	¥ -0.59	¥ -0.89
Diluted EPS	¥ 0.03	¥ -0.79	¥ -0.79	¥ -0.59	¥ -0.89
Weighted Average Shares Outstanding	3.78B	1.92B	2.42B	2.42B	2.41B
Weighted Average Shares Outstanding (Diluted)	3.99B	1.93B	2.42B	2.42B	2.41B

Currency in CNY

QuantumPharm, Inc. (2228) Income Statement

QuantumPharm, Inc. Income Statement

QuantumPharm, Inc. Earnings and Revenue History